Parenteral anticoagulants associated with lower risk in COVID-19

Chinese study found a composite outcome was significantly better in those on the therapy
Medicom Staff writer

AusDoc brings you the latest news from the European Society of Cardiology Congress 2020.

A study of 1125 patients admitted to hospital with COVID-19 in Wuhan shows that use of anticoagulants, particularly administered parenterally, gave better outcomes.